Barth syndrome

Barth syndrome (BTHS), also referred to as 3-methylglutaconic aciduria type II is an extremely rare X-linked multi-system disorder that is usually diagnosed in infancy.

It is characterised by:

BTHS has an estimated prevalence of 1 in 300,000-400,000 live births.

BTHS is caused by a tafazzin gene which encodes an acyltransferase responsible for remodeling of cardiolipin in mitochondrial membranes, especially affecting cardiac myocytes, neutrophils and skeletal muscles. The inheritance pattern is X-linked recessive type 6.

Echocardiography

Echocardiography may reveal left ventricular dilatation, hypertrophy of left ventricle and endocardial fibroelastosis. Cardiomyopathy can develop in utero 6.

It was first described by P G Barth et al 2-4  in the year 1983.

Share article

Article information

rID: 15721
Section: Syndromes
Synonyms or Alternate Spellings:
  • Barth syndrome (BTHS)
  • Barth's syndrome
  • X-linked cardioskeletal myopathy
  • 3-methylglutaconic acid-uria type II
  • Endocardial fibroelastosis type 2
  • Cardioskeletal Myopathy, Barth Type
  • Cardioskeletal Myopathy With Neutropenia and Abnormal Mitochondria
  • X-Linked Cardioskeletal Myopathy and Neutropenia

Support Radiopaedia and see fewer ads

Updating… Please wait.
Loadinganimation

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.